Scott Biller

Insider Reports History

Entity
Individual
Location
C/O Agios Pharmaceuticals, Inc., 38 Sidney Street, 2 Nd Floor, Cambridge, MA
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Scott Biller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Biller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Director Stock Options (Right to buy) 16K $88.3K $5.52 Jun 26, 2024 Direct

Insider Reports Filed by Scott Biller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Jun 26, 2024 1 $88.3K 4 Jun 28, 2024 Director
FHTX Foghorn Therapeutics Inc. Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
FHTX Foghorn Therapeutics Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
FHTX Foghorn Therapeutics Inc. Jul 13, 2021 1 $0 4 Jul 14, 2021 Director